Dr. Given is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 Clearfield Ave
Virginia Beach, VA 23462Phone+1 757-457-5177Fax+1 757-962-8020
Education & Training
University of FloridaResidency, Urology, 1993 - 1994
Virginia Commonwealth University Health SystemResidency, Urology, 1990 - 1993- Virginia Commonwealth University Health SystemResidency, Surgery, 1988 - 1990
Virginia Commonwealth University School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 1990 - 2026
NC State Medical License 1995 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
- Salvage Cryotherapy in Recurrent Prostate Cancer Start of enrollment: 2007 Jan 01
- Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 202 citationsApalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyKim N. Chi, Simon Chowdhury, Anders Bjartell, Byung Ha Chung, Andrea J. Pereira de Santana Gomes
Journal of Clinical Oncology. 2021-04-29 - 767 citationsApalutamide for Metastatic, Castration-Sensitive Prostate Cancer.Kim N. Chi, Neeraj Agarwal, Anders Bjartell, Byung Ha Chung, Andrea J. Pereira de Santana Gomes
The New England Journal of Medicine. 2019-05-31 - 3 citationsProstate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland CryoablationYaw A. Nyame, Ahmed Elshafei, Daniel Greene, Hans Arora, Robert Given
Journal of Endourology. 2017-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
